All of these cases were negative for MOG and AQP4 antibodies and did not evolve into MS, MOGAD, NMOSD, or ADEM over the follow-up period, thus remaining classified as monophasic demyelinating events (Table 1). Here, AQP4 is linked to myeloid sarcoma.